Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR

Kitsada Wudhikarn, Megan M. Herr, Min Chen, Michael J. Martens, John H. Baird, Lohith Gowda, Hemalatha G. Rangarajan, Muhammad Bilal Abid, Mohamed A. Kharfan-Dabaja, Kirsten M. Williams, Siddhartha Ganguly, Jo-Anne H. Young, Akshay Sharma, Giancarlo Fatobene, Tania Jain, Christopher G. Kanakry, Dipenkumar Modi, Natalie S. Grover, Baheyeldin Salem, Marjorie Vieira Batista, Paschalis Vergidis, Dwight E. Yin, Amer M. Beitinjaneh, Amar H. Kelkar, Taiga Nishihori, Jennifer Holter Chakrabarty, Usama Gergis, Melody Smith, Zeinab El Boghdadly, Christopher E. Dandoy, Hemant S. Murthy, Anna R. Huppler, Miguel-Angel Perales, Roy F. Chemaly, Joshua A. Hill, Marcie Riches, Jeffery J. Auletta

Open source

DOI
10.1182/bloodadvances.2025016141
Published
2025-10-30
Container
Blood Advances
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2025016141,
  title = {Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR},
  author = {Kitsada Wudhikarn and Megan M. Herr and Min Chen and Michael J. Martens and John H. Baird and Lohith Gowda and Hemalatha G. Rangarajan and Muhammad Bilal Abid and Mohamed A. Kharfan-Dabaja and Kirsten M. Williams and Siddhartha Ganguly and Jo-Anne H. Young and Akshay Sharma and Giancarlo Fatobene and Tania Jain and Christopher G. Kanakry and Dipenkumar Modi and Natalie S. Grover and Baheyeldin Salem and Marjorie Vieira Batista and Paschalis Vergidis and Dwight E. Yin and Amer M. Beitinjaneh and Amar H. Kelkar and Taiga Nishihori and Jennifer Holter Chakrabarty and Usama Gergis and Melody Smith and Zeinab El Boghdadly and Christopher E. Dandoy and Hemant S. Murthy and Anna R. Huppler and Miguel-Angel Perales and Roy F. Chemaly and Joshua A. Hill and Marcie Riches and Jeffery J. Auletta},
  year = {2025},
  journal = {Blood Advances},
  doi = {10.1182/bloodadvances.2025016141},
  url = {https://doi.org/10.1182/bloodadvances.2025016141}
}

RIS

TY  - JOUR
TI  - Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
AU  - Kitsada Wudhikarn
AU  - Megan M. Herr
AU  - Min Chen
AU  - Michael J. Martens
AU  - John H. Baird
AU  - Lohith Gowda
AU  - Hemalatha G. Rangarajan
AU  - Muhammad Bilal Abid
AU  - Mohamed A. Kharfan-Dabaja
AU  - Kirsten M. Williams
AU  - Siddhartha Ganguly
AU  - Jo-Anne H. Young
AU  - Akshay Sharma
AU  - Giancarlo Fatobene
AU  - Tania Jain
AU  - Christopher G. Kanakry
AU  - Dipenkumar Modi
AU  - Natalie S. Grover
AU  - Baheyeldin Salem
AU  - Marjorie Vieira Batista
AU  - Paschalis Vergidis
AU  - Dwight E. Yin
AU  - Amer M. Beitinjaneh
AU  - Amar H. Kelkar
AU  - Taiga Nishihori
AU  - Jennifer Holter Chakrabarty
AU  - Usama Gergis
AU  - Melody Smith
AU  - Zeinab El Boghdadly
AU  - Christopher E. Dandoy
AU  - Hemant S. Murthy
AU  - Anna R. Huppler
AU  - Miguel-Angel Perales
AU  - Roy F. Chemaly
AU  - Joshua A. Hill
AU  - Marcie Riches
AU  - Jeffery J. Auletta
PY  - 2025
JO  - Blood Advances
DO  - 10.1182/bloodadvances.2025016141
UR  - https://doi.org/10.1182/bloodadvances.2025016141
ER  - 

APA

Wudhikarn, K., Herr, M. M., Chen, M., Martens, M. J., Baird, J. H., Gowda, L., Rangarajan, H. G., Abid, M. B., Kharfan-Dabaja, M. A., Williams, K. M., Ganguly, S., Young, J. H., Sharma, A., Fatobene, G., Jain, T., Kanakry, C. G., Modi, D., Grover, N. S., Salem, B., Batista, M. V., Vergidis, P., Yin, D. E., Beitinjaneh, A. M., Kelkar, A. H., Nishihori, T., Chakrabarty, J. H., Gergis, U., Smith, M., Boghdadly, Z. E., Dandoy, C. E., Murthy, H. S., Huppler, A. R., Perales, M., Chemaly, R. F., Hill, J. A., Riches, M., & Auletta, J. J. (2025). Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR. Blood Advances. https://doi.org/10.1182/bloodadvances.2025016141

Source records